ETNB - 89bio announces proposed underwritten public offering of common stock and pre-funded warrants
2023-12-06 16:39:37 ET
More on 89bio
- 89bio's Low Price Presents An Opportunity
- 89bio: Risk And Reward Balance In NASH Therapeutics
- 89bio aligns with regulators on Phase 3 trials for NASH candidate
- 89bio gains FDA breakthrough status for NASH candidate
- Seeking Alpha’s Quant Rating on 89bio
For further details see:
89bio announces proposed underwritten public offering of common stock and pre-funded warrants